Table 1 Demographic and disease features of the patients before FESS
Group | Control | FESS |
|---|---|---|
Sex | Male: 15; female: 17 | Male: 18; female: 14 |
Age | 33.23 (20 – 66) | 35.82 (26 – 58) |
Weight (kg) | 62 (55 – 68) | 60 (51 – 71) |
Duration of UC (months) | 28 (15 – 68) | 35 (29 – 78) |
Prednisolone equivalent (mg/day) | 15 (5 – 20) | 15 (5 – 20) |